Ironshore Therapeutics, Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Drug Delivery

Other Names/Subsidiaries

  • Ironshore Pharmaceuticals & Development
See more in Biomedtracker

Latest on Ironshore Therapeutics, Inc.

In Vivo

Financing Quarterly Statistics, Q3 2024

 
• By Maureen Riordan and Deanna Kamenski

Biopharma financing during the third quarter of 2024 totaled $17bn from 207 deals. Of those, 54 reached $100m or more. The follow-on public offering (FOPO) category made up the made up most (34%) of t

Scrip

Deal Watch: Revance To Go Private In Crown Laboratories Buyout

 
• By Joseph Haas and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Crown Will Offer $924m To Merge With Re